CD274 and neoplasm: The detection of PD-L1/PD-1 expression levels in tumor tissues does not fully reflect and predict the efficacy of the treatment, and the high cost and long duration of treatment with immune checkpoint inhibitors are all challenges for the wide application of immune checkpoint inhibitors in the clinic.